Ready Capital Corp 5.75% NT REDEEM 15/02/2026 USD 25 RCC 深 滬
已收盤 09-05 16:00:00 美东时间
24.82
+0.030
+0.12%
華盛通- 最 高24.82
- 今 開24.75
- 成交量 1830股
- 最 低 24.75
- 昨 收 24.79
- 總市值 1.31亿
- 52周最高 26.1513
- 市盈率 靜 --
- 換手率 0.03%
- 52周最低 22.9125
- 委 比 0.00%
- 總股本 527.41万
- 歷史最高 26.1513
- 量 比 0.50
- 振 幅 0.28%
- 歷史最低 17.8969
- 每 手 1
- 風險率 0.50%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Exelixis shuttering Pennsylvania site, laying off 130 employees
Exelixis (NASDAQ:EXEL) is shutting down a facility in King of Prussia, Pa., to focus its operations at its headquarters in Alameda, Calif. As a result, 130 employees will be laid off, according to Fie...
09-04 22:19
Regency Centers to Present at the BofA Securities 2025 Global Real Estate Conference
Regency Centers Corporation announced that its management team will present at the BofA Securities 2025 Global Real Estate Conference on September 9, 2025, at 2:15 p.m. ET. The presentation will be available via webcast, with a replay accessible on the Company’s website within 24 hours. Regency Centers, a leading owner, operator, and developer of shopping centers, is an S&P 500 REIT focused on properties in suburban areas with strong demographics...
09-02 12:15
Telix Gets Second FDA Rejection For Kidney Cancer Drug
FDA sent a second CRL to Telix, delaying its kidney cancer PET drug. Analysts weigh pricing pressure, and growth opportunities.
08-29 01:08
Trevi Therapeutics to Participate in Upcoming September Conferences
NEW HAVEN, Conn., Aug. 28, 2025 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalb...
08-28 19:30
中国信通院李洁等：算力电力协同发展内涵与关键举措研究
0 引言 算力作为数智时代的新质生产力，是推动数字经济发展的重要引擎，正以前所未有的广度和深度向经济社会各领域渗透融合。在“双碳”目标背景下，我国积...
08-15 15:45
Rogers enters into definitive agreement to sell portfolio of data centres
Rogers Communications Inc. has agreed to sell its nine Rogers Business data centres to InfraRed Capital Partners, part of Sun Life. Rogers will continue to provide data centre services and network connectivity to the facilities. Proceeds from the sale will be used to repay debt, with the transaction expected to close by year-end 2025, subject to regulatory approval and other conditions. The transaction does not include Rogers' corporate data cent...
08-14 13:00
国金医药甘坛焕丨创新药前瞻深度：从IL-2双抗，看TAA、细胞及趋化因子的PD-1升级新方向
（来源：国金证券研究所） 作者：甘坛焕、赵海春 摘要 背景 创新药BD（授权合作交易）及其首付额爆发，下一个十亿美元首付花落谁家成市场新焦点。（...
08-14 07:34
跨国药企洞察｜默沙东终止康方2亿美元合作项目，跨国药企如何“优中选优”？
（来源：动脉新医药） 编者按： 全球视野下的跨国药企深度洞察——创新、博弈与中国答卷 在全球医药产业发展的宏大叙事中，跨国药企始终扮演着关键角色——他们...
08-12 08:02
增长11%！阿斯利康2025H1财报：营收280亿美元，Enhertu大卖22.89亿美元
（来源：抗体圈） 7月29日，跨国药企巨头阿斯利康（AstraZeneca）发布2025年上半年财报，交出一份超预期的成绩单：总营收达280.45亿美元（按固定...
07-31 09:23
